$9.70
▲ +2.0% Today
as of Jul 22, 16:46 ET
Last 30 days
Recent Press Releases & News
BioCryst to Report Second Quarter 2026 Financial Results on August 5
BioCryst Appoints David W. Jenkins as Chief Scientific Officer
Wall Street Analysts Think BioCryst (BCRX) Could Surge 117.96%: Read This Before Placing a Bet
Overview
52-week range
$6.00
$11
71% of range
Avg surprise (last 3)
+116.7%
Avg reaction (last 2)
+10.7%
50% positive
Latest IV / EM
54%
EM ±12.4% · $10 · Aug 21
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Wed May 6, 2026 | Mar/2026 | $-0.03 | $0.06 | -150.0% | — | -2.2% | earnings |
| Tue Sep 30, 2025 | Sep 2025 | $0.06 | — | — | — | — | financials |
| Mon Aug 4, 2025 | Jun/2025 | $0.15 | $0.03 | +400.0% | — | — | earnings |
| Mon May 5, 2025 | Mar/2025 | — | $-0.07 | +100.0% | — | +23.5% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $-0.07 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-0.06 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $-0.17 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $-0.19 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $-0.40 | — | — | — | — | financials |
Upcoming
| Date | Fiscal | Time | EPS Est | LY EPS | YoY %Δ |
|---|---|---|---|---|---|
| Mon Aug 3, 2026 | Jun/2026 | OTHER | $0.14 | $0.15 | -6.7% |
Financials
Income statement (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of revenue | $5M | — | $2M | $3M | $5M | — | $3M | $2M |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $-702M | — | $30M | $30M | $21M | — | $8M | $9M |
| Net income | $-722M | — | $13M | $5M | $32,000 | — | $-14M | $-13M |
| EPS (diluted) | $-2.98 | — | $0.06 | $0.02 | — | — | $-0.07 | $-0.06 |
Balance sheet (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $172M | $90M | $84M | $88M | $105M | $105M | $97M | $78M |
| Inventory | $6M | $5M | $5M | $5M | $7M | $8M | $8M | $4M |
| Total current assets | $374M | $404M | $356M | $398M | $410M | $422M | $427M | $363M |
| Total assets | $465M | $514M | $446M | $457M | $480M | $490M | $491M | $472M |
| Long-term debt | $395M | $0 | $194M | $243M | $315M | $315M | $314M | $314M |
| Total liabilities | $1.02B | $633M | $834M | $879M | $932M | $966M | $960M | — |
| Total equity | $-554M | $-119M | $-388M | $-422M | $-452M | $-476M | $-469M | $-476M |